The US Peptide Therapeutics Market holds a dominant share of the global industry, driven by a strong biopharmaceutical ecosystem, advanced healthcare infrastructure, and significant investments in drug research and development. The country has witnessed growing demand for peptide-based therapies for the treatment of diabetes, cancer, obesity, and rare diseases, supported by increasing disease...